Fan H, Liu X, Zheng W-W, Zhuang Z-H, Wang C-D
Department of Gastroenterology, The First Affiliated Hospital of Fujian Medical University, Fuzhou, Fujian, China.
Eur Rev Med Pharmacol Sci. 2020 Jul;24(14):7544. doi: 10.26355/eurrev_202007_22181.
Since this article has been suspected of research misconduct and the corresponding authors did not respond to our request to prove originality of data and figures, "MiR-150 alleviates EMT and cell invasion of colorectal cancer through targeting Gli1, by H. Fan, X. Liu, W.-W. Zheng, Z.-H. Zhuang, C.-D. Wang, published in Eur Rev Med Pharmacol Sci 2017; 21 (21): 4853-4859-PMID: 29164577" has been withdrawn. The Publisher apologizes for any inconvenience this may cause. https://www.europeanreview.org/article/13726.
由于本文涉嫌研究不当行为，且通讯作者未回应我们对数据和图表原创性进行证明的要求，“H. Fan、X. Liu、W.-W. Zheng、Z.-H. Zhuang、C.-D. Wang发表于《欧洲医学与药理学评论》2017年；21(21):4853 - 4859 - PMID: 29164577的‘MiR-150通过靶向Gli1减轻结直肠癌的EMT和细胞侵袭’”已被撤回。出版方对由此可能造成的任何不便表示歉意。https://www.europeanreview.org/article/13726 。
